The present invention provides a fused heterocyclic compound that has CDK 8 and/or CDK 19 inhibitory activity. The present invention provides a compound represented by formula (I)
(wherein the symbols are as defined in the description) or a salt thereof.
申请公布号
EP3133075(A1)
申请公布日期
2017.02.22
申请号
EP20150779993
申请日期
2015.04.16
申请人
Takeda Pharmaceutical Company Limited
发明人
OKANIWA, Masanori;BANNO, Hiroshi;HIRAYAMA, Takaharu;CARY, Douglas Robert;ONO, Koji;IWAMURA, Naoki
